Conduct of pharmacovigilance for medicines used by the paediatric population

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMEA/CHMP/235910/05
Published25/01/2007
Effective from26/01/2007
KeywordsPharmacovigilance, safety, paediatrics, children, neonates, adverse drug reaction (ADR), periodic safety update report (PSUR), risk management plan (RMP), signal detection, patient information leaflet
DescriptionThis document provides guidance on the conduct of pharmacovigilance for medicines used by paediatric population. It applies to ‘off-label’ and unlicensed as well as licensed use.


Document history

First version

Current version

Adopted guideline


Overview of comments


Draft guideline

 

Concept paper

In operation: 01/01/2010–present


Published: 27/06/2007


Published: 27/07/2005

 

Published: 17/10/2002


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more